Typhoid fever
Therapeutic area
Infectious Disease
Rare disease
Yes
- Definition
- A bacterial infectious disorder contracted by consumption of food or drink contaminated with Salmonella typhi. This disorder is common in developing countries and can be treated with antibiotics.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Typhoid fever
- Therapeutic area
- Infectious Disease
- typhoid fever
- typhoid
- typhoid fever
- typhoidal salmonellosis
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Severe
- MONDO ID
- MONDO:0005619
- Parent condition
- MONDO:0000827
Related records
Broader conditions (8)
- Bacterial infectious disease
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Primary bacterial infectious disease
- Salmonellosis
Trials (71)
- A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
- A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
- Blood Donor CVD 5000
- Challenge Non-Typhoidal Salmonella (CHANTS) Study
- Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
- Co-administration Study of OCV, TCV and MR
- Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
- Commercial Typhoid Tests Validation
- Commercial Typhoid Tests Validation Trial
- Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
- COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT SALMONELLA TYPHI IN TERMS OF TIME TO DEFERVESCENCE
- Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children
- CVD 909 Vi Prime Boost Study
- Diagnosis and Staging of Typhoid Fever Using Surface-enhanced Raman Spectroscopy Liquid Biopsy
- Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
- Effectiveness of a Typhoid Conjugate Vaccine in DRC
- Effects of Aging on Primary and Secondary Vaccine Responses
- Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever
- Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
- Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
Approved drugs (1)
- Ciprofloxacin
Drugs in development (3)
- Pertussis vaccine Phase 1
- Salmonella typhi TY2 VI polysaccharide antigen Phase 1
- Tetanus toxoid Phase 1
Other linked drugs (3)
- Ampicillin
- Levofloxacin
- Nalidixic acid